For the quarter ending 2026-03-31, COLL made $193,520K in revenue. $14,496K in net income. Net profit margin of 7.49%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Product revenues, net | 193,520 | 205,449 | 209,361 | 188,000 |
| Intangible asset amortization and impairment | - | - | 55,473 | 55,473 |
| Cost of product revenues (excluding intangible asset amortization) | 20,801 | 21,598 | 24,717 | 24,143 |
| Intangible asset amortization | 55,473 | 55,473 | - | - |
| Total cost of product revenues | 76,274 | 77,071 | 80,190 | 79,616 |
| Gross profit | 117,246 | 128,378 | 129,171 | 108,384 |
| Selling, general and administrative | 86,350 | 67,640 | 67,103 | 73,637 |
| Gain on fair value remeasurement of contingent consideration | 0 | -19 | -19 | -358 |
| Total operating expenses | 86,350 | 67,621 | 67,084 | 73,279 |
| Income from operations | 30,896 | 60,757 | 62,087 | 35,105 |
| Interest income | - | - | 3,116 | 2,383 |
| Interest expense | 15,862 | 19,292 | 21,767 | 20,463 |
| Interest income | 3,706 | 2,822* | - | - |
| Loss on extinguishment of debt | - | -15,251* | - | - |
| Income before income taxes | 18,740 | 29,036 | 43,436 | 17,025 |
| Provision for income taxes | 4,244 | 12,073 | 11,929 | 5,042 |
| Net income | 14,496 | 16,963 | 31,507 | 11,983 |
| Basic EPS | 0.45 | 0.536 | 1 | 0.38 |
| Diluted EPS | 0.4 | 0.357 | 0.84 | 0.34 |
| Basic Average Shares | 32,087,472 | 31,649,955 | 31,571,410 | 31,810,612 |
| Diluted Average Shares | 40,065,665 | 47,451,026 | 39,439,890 | 39,075,703 |
COLLEGIUM PHARMACEUTICAL, INC (COLL)
COLLEGIUM PHARMACEUTICAL, INC (COLL)